NEOGEN CORP (NEOG) Fundamental Analysis & Valuation

NASDAQ:NEOG • US6404911066

Current stock price

8.7 USD
-0.45 (-4.92%)
At close:
8.7 USD
0 (0%)
After Hours:

This NEOG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NEOG Profitability Analysis

1.1 Basic Checks

  • In the past year NEOG was profitable.
  • In the past year NEOG had a positive cash flow from operations.
  • In multiple years NEOG reported negative net income over the last 5 years.
  • NEOG had a positive operating cash flow in each of the past 5 years.
NEOG Yearly Net Income VS EBIT VS OCF VS FCFNEOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • NEOG has a Return On Assets (-17.94%) which is comparable to the rest of the industry.
  • With a Return On Equity value of -28.64%, NEOG perfoms like the industry average, outperforming 54.50% of the companies in the same industry.
Industry RankSector Rank
ROA -17.94%
ROE -28.64%
ROIC N/A
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
NEOG Yearly ROA, ROE, ROICNEOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • NEOG has a Gross Margin (45.98%) which is in line with its industry peers.
  • NEOG's Gross Margin has been stable in the last couple of years.
  • NEOG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
NEOG Yearly Profit, Operating, Gross MarginsNEOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. NEOG Health Analysis

2.1 Basic Checks

  • NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NEOG remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, NEOG has more shares outstanding
  • Compared to 1 year ago, NEOG has a worse debt to assets ratio.
NEOG Yearly Shares OutstandingNEOG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
NEOG Yearly Total Debt VS Total AssetsNEOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • NEOG has an Altman-Z score of 1.12. This is a bad value and indicates that NEOG is not financially healthy and even has some risk of bankruptcy.
  • NEOG has a Altman-Z score of 1.12. This is comparable to the rest of the industry: NEOG outperforms 51.32% of its industry peers.
  • A Debt/Equity ratio of 0.38 indicates that NEOG is not too dependend on debt financing.
  • NEOG has a Debt to Equity ratio of 0.38. This is comparable to the rest of the industry: NEOG outperforms 48.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.12
ROIC/WACCN/A
WACC10.78%
NEOG Yearly LT Debt VS Equity VS FCFNEOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 3.91 indicates that NEOG has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.91, NEOG is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
  • A Quick Ratio of 2.80 indicates that NEOG has no problem at all paying its short term obligations.
  • The Quick ratio of NEOG (2.80) is better than 62.43% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 2.8
NEOG Yearly Current Assets VS Current LiabilitesNEOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NEOG Growth Analysis

3.1 Past

  • The earnings per share for NEOG have decreased strongly by -27.50% in the last year.
  • The earnings per share for NEOG have been decreasing by -10.20% on average. This is quite bad
  • NEOG shows a decrease in Revenue. In the last year, the revenue decreased by -3.67%.
  • The Revenue has been growing by 16.43% on average over the past years. This is quite good.
EPS 1Y (TTM)-27.5%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-9.09%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-2.84%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.29% on average over the next years.
  • Based on estimates for the next years, NEOG will show a decrease in Revenue. The Revenue will decrease by -0.50% on average per year.
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue Next Year-4.55%
Revenue Next 2Y-1.49%
Revenue Next 3Y-0.67%
Revenue Next 5Y-0.5%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NEOG Yearly Revenue VS EstimatesNEOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
NEOG Yearly EPS VS EstimatesNEOG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

2

4. NEOG Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 30.00, the valuation of NEOG can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of NEOG indicates a somewhat cheap valuation: NEOG is cheaper than 73.55% of the companies listed in the same industry.
  • NEOG is valuated rather expensively when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 25.65, NEOG can be considered very expensive at the moment.
  • 73.02% of the companies in the same industry are more expensive than NEOG, based on the Price/Forward Earnings ratio.
  • NEOG is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30
Fwd PE 25.65
NEOG Price Earnings VS Forward Price EarningsNEOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NEOG is valued a bit cheaper than the industry average as 69.84% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.87
NEOG Per share dataNEOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.38%
EPS Next 3Y9.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEOG Dividend Analysis

5.1 Amount

  • NEOG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEOG Fundamentals: All Metrics, Ratios and Statistics

NEOGEN CORP

NASDAQ:NEOG (3/27/2026, 8:00:01 PM)

After market: 8.7 0 (0%)

8.7

-0.45 (-4.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-08
Earnings (Next)04-01
Inst Owners104.06%
Inst Owner Change-16.56%
Ins Owners0.65%
Ins Owner Change24.72%
Market Cap1.89B
Revenue(TTM)880.32M
Net Income(TTM)-602.74M
Analysts78.18
Price Target11.22 (28.97%)
Short Float %4.6%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)87.17%
Min EPS beat(2)78.25%
Max EPS beat(2)96.08%
EPS beat(4)2
Avg EPS beat(4)32.2%
Min EPS beat(4)-34.64%
Max EPS beat(4)96.08%
EPS beat(8)3
Avg EPS beat(8)11.3%
EPS beat(12)5
Avg EPS beat(12)119.18%
EPS beat(16)6
Avg EPS beat(16)37.27%
Revenue beat(2)2
Avg Revenue beat(2)3.22%
Min Revenue beat(2)0.46%
Max Revenue beat(2)5.99%
Revenue beat(4)2
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-3.66%
Max Revenue beat(4)5.99%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)4
Avg Revenue beat(12)-0.24%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)0%
PT rev (3m)44.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.69%
EPS NY rev (1m)0%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.31%
Valuation
Industry RankSector Rank
PE 30
Fwd PE 25.65
P/S 2.15
P/FCF N/A
P/OCF 28.59
P/B 0.9
P/tB N/A
EV/EBITDA 29.87
EPS(TTM)0.29
EY3.33%
EPS(NY)0.34
Fwd EY3.9%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.3
OCFY3.5%
SpS4.05
BVpS9.67
TBVpS-1.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.95
Profitability
Industry RankSector Rank
ROA -17.94%
ROE -28.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.98%
FCFM N/A
ROA(3y)-10.81%
ROA(5y)-4.19%
ROE(3y)-17.92%
ROE(5y)-8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.72%
GM growth 5Y0.07%
F-Score4
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 8.98
Cap/Depr 71.99%
Cap/Sales 9.62%
Interest Coverage N/A
Cash Conversion 74.97%
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 2.8
Altman-Z 1.12
F-Score4
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)85.8%
Cap/Depr(5y)97.5%
Cap/Sales(3y)10.58%
Cap/Sales(5y)8.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.5%
EPS 3Y-9.82%
EPS 5Y-10.2%
EPS Q2Q%-9.09%
EPS Next Y-9.33%
EPS Next 2Y1.38%
EPS Next 3Y9.52%
EPS Next 5Y7.29%
Revenue 1Y (TTM)-3.67%
Revenue growth 3Y19.28%
Revenue growth 5Y16.43%
Sales Q2Q%-2.84%
Revenue Next Year-4.55%
Revenue Next 2Y-1.49%
Revenue Next 3Y-0.67%
Revenue Next 5Y-0.5%
EBIT growth 1Y-193.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.34%
EBIT Next 3Y34.61%
EBIT Next 5Y20.01%
FCF growth 1Y-209.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.22%
OCF growth 3Y-5.05%
OCF growth 5Y-7.47%

NEOGEN CORP / NEOG Fundamental Analysis FAQ

What is the fundamental rating for NEOG stock?

ChartMill assigns a fundamental rating of 3 / 10 to NEOG.


What is the valuation status of NEOGEN CORP (NEOG) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEOGEN CORP (NEOG). This can be considered as Overvalued.


How profitable is NEOGEN CORP (NEOG) stock?

NEOGEN CORP (NEOG) has a profitability rating of 3 / 10.


What is the financial health of NEOGEN CORP (NEOG) stock?

The financial health rating of NEOGEN CORP (NEOG) is 4 / 10.


What is the expected EPS growth for NEOGEN CORP (NEOG) stock?

The Earnings per Share (EPS) of NEOGEN CORP (NEOG) is expected to decline by -9.33% in the next year.